ESC 365 - Terminal glycosylation pattern as a determinant of human iPSC-derived cardiomyocytes transduction with AAV vectors

CBS PREMIUM ACCESS

Terminal glycosylation pattern as a determinant of human iPSC-derived cardiomyocytes transduction with AAV vectors

Session: Moderated poster 6 - Stem cells

Topic: Gene Therapy, Cell Therapy

Speaker: Ms I. Kraszewska (Krakow, PL)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

About the speaker

Ms Izabela Kraszewska

Jagiellonian University, Krakow (Poland)

0 follower

3 more presentations in this session

Doxorubicin-induced cardiomyopathy is modulated by Hippo signalling

A single cell transcriptional roadmap of human pacemaker cell differentiation

Speaker: Miss A. Wiesinger (NL)

Telomerase and myocardin co-expressing mesenchymal cells increase survival and induce cardiac and vascular markers in cardiac stromal cells undergoing simulated ischemia/reperfusion

Speaker: Assistant Professor R. Madonna (Pisa, IT)

Access the full session

Moderated poster 6 - Stem cells

Speakers: Ms I. Kraszewska, Miss A. Wiesinger, Assistant Professor R. Madonna

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by